Caption Management’s AnaptysBio ANAB Stock Holding History

Caption Management’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-200,000	Closed	-$9.7M	–	1521
2025 Q4	$9.7M	Buy	+200,000	New	+$7.8M	0.07%	342
2025 Q1	–	Sell	-402,300	Closed	-$5.33M	–	1483
2024 Q4	$5.33M	Buy	402,300 +252,600	+169%	+$6.12M	0.05%	347
2024 Q3	$5.01M	Buy	+149,700	New	+$5.11M	0.08%	294
2024 Q1	–	Sell	-26,500	Closed	-$568K	–	1166
2023 Q4	$568K	Buy	26,500 +1,500	+6%	+$25.9K	0.01%	926
2023 Q3	$449K	Sell	25,000 -2,000	-7%	-$38.2K	0.01%	956
2023 Q2	$549K	Sell	27,000 -3,000	-10%	-$60.8K	0.01%	797
2023 Q1	$653K	Buy	+30,000	New	+$729K	0.01%	732
2020 Q1	–	Sell	-92,900	Closed	-$1.51M	–	843
2019 Q4	$1.51M	Buy	+92,900	New	+$2.2M	0.05%	412
2019 Q2	–	Sell	-30,000	Closed	-$2.19M	–	645
2019 Q1	$2.19M	Buy	+30,000	New	+$2.07M	0.12%	225
2018 Q4	–	Sell	-30,000	Closed	-$2.99M	–	462
2018 Q3	$2.99M	Buy	+30,000	New	+$2.49M	0.17%	167

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Caption Management's ANAB Position: Q2 2025 in Review

Caption Management sold out of AnaptysBio (ANAB) in Q2 2025, closing a stake of 23,376 shares — an estimated $435K sold.

Caption Management first reported a position in ANAB in Q3 2019 and held it in 12 quarters. The position peaked at $1.98M in Q2 2020. 147 funds tracked by Wall St. Rank hold ANAB as of Q2 2025.

Caption Management reported no remaining AnaptysBio position as of Q2 2025 after selling out during the quarter.
Caption Management sold 23,376 AnaptysBio shares in Q2 2025, an estimated $435K.
Caption Management first reported a position in AnaptysBio in Q3 2019 and held it in 12 quarters.
Caption Management's AnaptysBio position peaked at $1.98M in Q2 2020.
147 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2025.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.